Evaluation of Treatment with Bosentan in Patients with Carcinoid Heart Disease: Single Center Study

Publisher： Karger

E-ISSN： 2296-5262|33|6|300-304

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.6, 2010-05, pp. : 300-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of carcinoid heart disease using delayed enhancement imaging

By Hrabak-Paar M.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 619-619

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension – A Multi-Center Randomized Study

By  

Cardiology, Vol. 109, Iss. 4, 2007-09 ,pp. : 273-280

Karger

Access to resources Recommend Favorite

Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center

By  

MUSCLE AND NERVE, Vol. 54, Iss. 4, 2016-10 ,pp. : 666-672

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiac Surgery for Carcinoid Heart Disease: A Weapon Not to Be Misused

By  

Cardiology, Vol. 136, Iss. 4, 2016-11 ,pp. : 243-251

Karger

Access to resources Recommend Favorite

Carcinoid Heart Disease without Severe Tricuspid Valve Involvement

By  

Cardiology, Vol. 133, Iss. 4, 2015-12 ,pp. : 217-222

Karger

Access to resources Recommend Favorite